Although results obtained by MRS are usually expressed as ratios of peak areas such as per to ATP , molar concentrations can be determined accurately by MRS provided an appropriate quantification procedure is applied. Because each peak area is proportional to the concentration of the corresponding metabolite, the individual concentrations can be estimated if the concentration of at least one metabolite, which can then be used as an internal concentration standard, is known. In 31p MRS studies on brain development, concentration estimates are generally assessed by assuming an age-independent [ATP) of about 2.8 mmol/L, This assumption is based on observations in the developing rat brain in which the cerebral [ATP) in neonatal and adult rats were found to be independent of age (I, 2) . With reference to these findings in animals, an age-independent [ATP) was also assumed for the human brain (6) . Several human 31p MRS studies coincidentally found an [ATP) of about 2.8 mmol/ L in the adult human brain (7) (8) (9) .
The purpose of this study was to determine the molar concentrations of phosphorus brain metabolites with in vivo 31p MRS in the human brain at different developmental ages and to test the hypothesis of an age-independent [ATP).
Subjects. Sixteen term neonates (mean postconceptional age 42 wk, range 39-44 wk), 17 infants (mean age 11 rno, range 6-20 mol , and 28 healthy adult volunteers (mean age 32 y, range 22-58 y) were studied . Of the 33 pediatric subjects, five were clinically healthy and six had a small hemorrhagic lesion outside the VOL Twenty-two of the 33 children were hospitalized for non neurologic reasons, e.g. infectious diseases or gastrointestinal problems. The parents of all children gave their oral or written consent after thorough oral and written explanation of the MR examination procedure. They were usually present with their child during the whole examination. The neonates and infants were sedated with chloral hydrate (50-100 rug/kg) given orally 431 Abbreviations MR, magnetic resonance MRS, magnetic resonance spectroscopy VOl, volume of interest CSF, cerebrospinal fluid PME, phospho monoester PDE, phosphodiester Pi, inorganic phosphate PCr, phosphocreatine pH.. intracellular pH (ATP), ATP concentration PEt, phosphorylethanolamine PCh, phosphorylchollne T h longitudinal relaxation time T1, transversal relaxation time ABSTRACT. Phosphorus magnetic resonance spectroscopy is a noninvasive method to investigate brain metabolism in vivo, ATP generally serves as an internal concentration standard for the quantification of the various phosphorus metabolites, because the ATP concentration in mammalian brains is assumed to be age independent. This presumption is based on observations made in the biochemical analysis of the developing rat brain. In the present study, metabolite concentrations were assessed with an external concentration standard. Each brain spectrum was quantified using a calibration spectrum that was acquired from a phantom after the in viva brain measurement. Fully relaxed localized brain spectra were obtained from 16 neonates (2-28 d), 17 infants (6-20 mol, and 28 adults (22-58 y). The metabolite concentrations (in mmol/L) changed from neonates to adults: phosphomonoester from 4.5 to 3.5, inorganic phosphate from 0.6 to 1.0, phosphodiester from 3.2 to 11.7, phosphocreatine from 1.4 to 3.4, and ATP from 1.6 to 2.9. We conclude that 1) the ATP concentration in the human brain almost doubles between neonates and adults, and 2) ATP may not be used as an age-independent internal concentration standard. (Pediatr Res35: [431] [432] [433] [434] [435] 1994) or via a nasogastric tube. Oxygen saturation, heart rate, and ECG were continuously measured in all children. The study including the sedation has been approved by the local ethical committee and by the Swiss Federal Research Council.
Instrumentation. All neonates and infants and seven adults were examined on a 2.35-Tesla MEOSPEC 24/40 (Bruker/ Spectrospin). In addition, measurements were made on 21 adults with 1.5-Tesla S15 Gyroscan (Philips). Because both spectrometers yielded almost identical mean cerebral metabolite concentrations with comparable standard deviations, the data of all 28 adults were treated together. Helmholtz type radiofrequency coils of different sizes were used as transmitter and receiver coils. For each volunteer, optimal pulse gains were applied using the previously determined relation between the matching capacitance and pulse gain required for the 90· pulse.
Localization. Image-guided spectroscopy was performed using the volume-selective pulse sequence ISIS (II). Figure I shows position and size of the volumes selected. VOl of 53, 6 3 , and 7 3 em! were selected in the brain of neonates, infants, and adults, respectively. The volumes composed approximately similar parts of the parietal lobes (:::::45 %), the frontal lobes (::::: 15%), the occipital lobes (::::: 10%), and the basal ganglia (:::::20%) in all three groups. The contribution of gray and white matter was also approximately similar for the three age groups. The relative composition of the VOl changed with respect to the CSF, which contributed 18 ± 3% in neonates, II ± 2% in infants, and 10 ± 2% in adults. The amount of CSF and the composition of the VOl were calculated in four subjects of each age group by performing an operator-guided planimetric analysis of eight to 10 frontal and transversal Tj-weighted multislice MR images. This method of CSF assessment was validated by comparing our results measured in adults with those determined from matched brain sections in an anatomical atlas (the correspondence was better than ± 12%). Because CSF contains almost no phosphorus (12), the metabolite concentrations obtained for neonates, infants, and adults were multiplied by a correction factor of 1/ 0.82, 1/0.89, and 1/0.90 , respectively.
Quantification. Quantification was achieved with a calibration phantom used as concentration standard. The calibration measurement was performed immediately after the in vivo investigation. The brain and the calibration measurements were identical with respect to all measurement parameters, the size and location of the volume selected, and the load of the radiofrequency coil ( Fig. 1) . The coil load for the calibration measurement was adjusted to match that of the brain examination in the following way: the matching capacitance of the radiofrequency coil was left unchanged after the in vivo measurement, and the coil load of the calibration measurement was successively increased with a saline bottle that was brought closer to the phantom-loaded coil in a stepwise fashion until optimal matching was achieved
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( Fig. I) . Head-shaped bottles containing 1, 2, or 4 L of 75 mmol/ L KH2PO. solution were used as phantoms for neonates, infants, and adults, respectively. The electrical conductivity of the solution [0' ::::: 0.58 siemen/m (13)] was slightly lower than that of human tissue [0'::::: 0.64 siemen/m (14) ] to allow fine adjustment of the coil load with the saline bottle. The initial T I of 9 s was shortened to I s through the addition of 0.04 g/L NiCh (no T 2 shortening).
Data acquisition. The position of the VOl was selected from MR images, which were available from the preceding routine examination. The time required to prepare the spectroscopy session was about 10 min and the acquisition time of a spectrum was 13 min. Fully relaxed spectra were collected with a repetition time of 12 s (4 times the longest T I ) and 64 scans were averaged to enhance the signal-to-noise ratio. The spin-lattice relaxation times T I of the 31p metabolites were determined in four neonates and five adults with saturation-recovery and inversion-recovery sequences.
Dataprocessing. The MRS signals (free induction decays) were fitted in the time domain with an iterative least-squares method (15 ms of the experimental signal were omitted for fitting to avoid the strong but fast-dephasing signal of the almost immobile membrane phospholipids. After iterative fitting, the first 2 ms of the experimental signal were replaced by the corresponding model signal. The experimental signal collected after the first 20 ms was also om itted because of the decreasing signal-to-noise ratio. The peak width of Pi was not fitted but kept constant at 14 Hz full-width-at-half-maximum because it often degenerates due to strong peak overlapping with PME and POE. In addition, the peak width of POE was kept constant at 60 Hz full-width-athalf-maximum to prevent its broadening due to the almost immobile membrane phospholipids.
Statistical analysis. Mean values of the various metabolite
concentrations were compared between the three age groups with the parametric two-sample t test. Values are expressed as means ± SO throughout this paper.
RESULTS
Figure 2 depicts three representative 31p brain spectra from one neonate (I wk), one infant (I y), and one adult (36 y). The chemical shifts are plotted along the abscissa and the peak intensities along the ordinate. The most obvious difference between the spectra of neonates and adults is a high PME but a In Vitro Calib. Meas. low POE in the former, and low PME but high POE in the latter. This change of pattern is typically observed during brain maturation. Table I lists the molar concentrations of the various human brain 31p metabolites in neonates, infants, and adults. Note that the concentrations of ATP, Pi, PCr, and POE all increased significantly by factors of 1.8, 1.9, 2.4, and 3.6, respectively, from birth to adulthood. During the same period, PME decreased by only 22%, despite its apparent relative fall in the spectra. The mean concentratton changes between neonates and adults were all significant. Table 2 depicts relevant ratios of peak areas for the three age groups. From birth to adulthood, the PCr-to-ATP and the PCrto-Pi ratios both increased by about 30%; the POE-to-PME ratio increased by a factor of 4.7. 8 s for per, 0.9 s for ,,-ATP, 1.1 s for a-ATP, and 1 .0 s for [3-ATP; they did not change with age. 
DISCUSSION
This study shows that the molar concentration of ATP in the human brain increases by a factor of 1.8 during maturation from 1.6 mmol/L in neonates to 2.9 mmol/L in adults. The adult value compares favorably to literature data from quantitative 31P MRS (7-9), but no neonatal concentrations are available in the literature. The following two observations can be interpreted to be in agreement with our result of an [ATPj increase in the human brain. First, the nonwater proportion in human brain increases from 10% in neonates to 23% in adults (17) and the total phosphorus concentration rises from 54 to 109 mmol/L (17) . Both changes are partly due to myelination but also to an increase of the concentration of cytosolic compounds (18, 19) . Second, the cerebral metabolic rate rises 5-fold for oxygen, tofold for glucose , and even 20-fold for ATP during brain development (19) and therefore makes a developmental [ATPj increase plausible, although a higher energy turnover does not automatically imply a higher [ATP] .
Although the adult [ATPj of about 2.9 mmol/L is similar in humans (7-9) and rats (4), the neonatal [ATPj seems to differ between the two species : it is about 2.5 mrnol/L in rat pups (2, 4) and about 1.6 mmol/L in human neonates (present study) ( Table 5 ). The higher [ATPj in rat pups than in human neonates could tentatively be explairied by a higher specific energy demand resulting from rapid growth and high heat dissipation, assuming a higher [ATPj is related to a faster energy turnover. Rat pups are probably more mature with respect to brain energy metabolism than human neonates, although the brain morphology of IO-d-old rat pups is comparable to that of term human neonates (20) .
Another aspect of paramount importance is the composition of the brain tissue investigated. In rats, the entire brain was investigated (cerebral hemispheres: ::::35 %, brain stem and basal ganglia: ::::65%) (I , 2) . On the other hand, in this study, we have mainly selected brain tissue from human cerebral hemispheres (cerebral hemispheres: ::::78%, basal ganglia: ::::22%). It is possible that, at birth, the [ATPj is higher in the brain stem and basal ganglia than in the cerebral hemispheres, because the neonatal metabolic rates of oxygen and glucose consumption are both 0.7 ± 0.2t higher in the former than the latter regions (19). In adults, these regional differences have a tendency to level out (19). The hypothesis of a postnatal increase in the [ATPj in the cerebral hemispheres in contrast to a constant concentration in the brain stem and the basal ganglia would explain the discrepancies between our study and studies on rats. Thus, the diverging results in neonatal human and rat pups are possibly due to different brain regions being analyzed rather than to interspecies differences. It has to be pointed out that the chemical analysis assesses pure ATP, whereas IIp MRS always detects all nucleoside triphosphates. Additionally, a certain amount of nucleoside triphosphate may be undetectable by l ip MRS. The PME and PDE signals are both composed of many different metabolites containing PME or PDE groups, respectively. PME is assigned to phospholipid precursors, whereas PDE is related to both phospholipid decomposition products (:::::20%) and phospholipids themselves (:::::80 %) (21, 22) . We found a relatively small diminution (only 22%) of PME concentration during maturation. This seems to be in contradiction to the reported 3-fold decrease of PEt (23, 24) ; PEt is a main component of PME. However, the two findings are consistent if the agedependent chemical composition of the PME signal is considered. The PEt contribution to PME is about 70% in neonatal brain (23, 25) but only 30% in adult brain (25, 26) . In contrast to PEt, the contribution of PCh rises from about 10% to more than 30% during brain maturation (24, 26, 27) . In the present in vivo study, the change in the PME composition could be observed through the upfield shift of the PME resonance (Table  3 ). In addition, the broadening of the PME resonance line expresses the change from an almost monocomponent peak into a multicomponent peak (Table 3) . Finally, the reduction of the T I relaxation time of PME can also be related to a reversion of the PEt and PCh contributions if a shorter relaxation time is assumed for PCh than for PEt (Table 3 ). All three findings indicate a change in the compos ition of PME. In contrast to PME concentration, PDE concentration rises steadily during the last quarter of gestation by a factor of 2.4 (10), from birth to adulthood by a factor of 3.7 (this study), and from adulthood to old age by a factor of 2 (28) .
We observed a decrease in human cerebral pHi of 0.09 U during postnatal maturation. This result compares favorably with the pH; diminution of 0.12 U found in dog brains during postnatal development (5) and follows the same tendency found in preterm humans (pl-l, fall of 0.05 U between 28 and 42 wk of postconceptional age) (29) .
To verify our concentration estimates, control examinations were performed with a circular surface coil positioned under the back of the head of three neonates and three adults. A rectangular pulse performing a 180· flip angle in the coil center was applied to the occipital lobe. Although somewhat less precise, this surface-coil method is more robust than the ISIS method and thus lesslikely to sutTer from any systematic error (30) . The calibration phantoms used had a wall thickness approximately equal to the distance between skin and brain. Almost identical results were obtained using the ISIS sequence in our study and a surface coil in the control examinations: the respective [ATPj were 1.54 and 1.67 mmol/L in neonates and 2.85 and 2.98 rnmol/L in adults. Therefore, we believe that the occurrence of severe systematic errors can be excluded.
In summary, we found that the [ATPj almost doubles during brain development of healthy human neonates to adults . Therefore, we conclude that ATP may not be used as an age-independent internal concentration standard in MRS studies measuring I I p metabolites in the human brain.
